Squadron Master Fund LP and Associates Report Ownership in NextCure, Inc.

Squadron Master Fund LP, Squadron Capital Management, LLC, Matthew Sesterhenn, and William Blank have filed a Schedule 13G to report their ownership in NextCure, Inc. Squadron Master Fund LP owns 5.8% of the common stock, while Squadron Capital Management, LLC, Matthew Sesterhenn, and William Blank each own 6.5%. The filing indicates that Squadron Capital Management, LLC is an investment adviser registered with the SEC, and it may be deemed the beneficial owner of the shares held by the Funds. Matthew Sesterhenn and William Blank, as partners of Squadron Capital Management, LLC, may also be deemed beneficial owners. The filing includes certifications that the securities were not acquired to influence control of the issuer.